Tempest Therapeutics (TPST) EBT (QoQ) (2012 - 2025)
Powered by 
Analysis
Tempest Therapeutics (TPST) EBT (QoQ) (2012 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Tempest Therapeutics | 3.35 Mn | 2.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -13.34% |
| Sep 30, 2025 | 55.10% |
| Jun 30, 2025 | 27.80% |
| Mar 31, 2025 | 21.66% |
| Dec 31, 2024 | -30.19% |
| Sep 30, 2024 | -9.30% |
| Jun 30, 2024 | -19.32% |
| Mar 31, 2024 | -5.72% |
| Dec 31, 2023 | -13.30% |
| Sep 30, 2023 | 10.99% |
| Jun 30, 2023 | 1.26% |
| Mar 31, 2023 | 15.39% |
| Dec 31, 2022 | -4.68% |
| Sep 30, 2022 | 2.41% |
| Jun 30, 2022 | -7.97% |
| Mar 31, 2022 | -10.62% |
| Dec 31, 2021 | 5.35% |
| Sep 30, 2021 | -14.91% |
| Jun 30, 2021 | -31.80% |
| Mar 31, 2021 | 84.34% |